Profile
Gary T.
Elliott worked as a Senior Director of Product Development at Corixa Corp.
from 1999 to 2002.
Prior to that, he was the Vice President of Pharmaceutical Development at Ribi ImmunoChem Research, Inc. from 1994 to 1999.
He then worked as the Vice President of Product Development at Salmedix, Inc. from 2002 to 2005.
After his time in the private sector, he became a Professor at The University of Arkansas.
Later, he worked as the Executive Vice President of Product Development at Aires Pharmaceuticals, Inc. Dr. Elliott received his undergraduate degree from Albany College of Pharmacy & Health Sciences and his doctorate from the University of Florida.
Former positions of Gary T. Elliott
| Companies | Position | End |
|---|---|---|
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Corporate Officer/Principal | 31/05/2005 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | 31/05/2002 |
| Ribi ImmunoChem Research, Inc. | Corporate Officer/Principal | 31/10/1999 |
| The University of Arkansas | Corporate Officer/Principal | - |
Aires Pharmaceuticals, Inc.
 Aires Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Aires Pharmaceuticals, Inc. develops drugs to treat pulmonary disorders. It offers Aironite, an inhaled drug that is used to treat adult and pediatric pulmonary hypertension, cystic fibrosis, pneumonia and other respiratory infections. The company was founded by Wendy S. Johnson in 2006 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Training of Gary T. Elliott
| Albany College of Pharmacy & Health Sciences | Undergraduate Degree |
| University of Florida | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Aires Pharmaceuticals, Inc.
Aires Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Aires Pharmaceuticals, Inc. develops drugs to treat pulmonary disorders. It offers Aironite, an inhaled drug that is used to treat adult and pediatric pulmonary hypertension, cystic fibrosis, pneumonia and other respiratory infections. The company was founded by Wendy S. Johnson in 2006 and is headquartered in San Diego, CA. | Health Services |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
| Ribi ImmunoChem Research, Inc. | Health Technology |
- Stock Market
- Insiders
- Gary T. Elliott